Boston Scientific CorporationBSXNYSE
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+16.5%
5Y CAGR+15.2%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+16.5%/yr
vs +6.6%/yr prior
5Y CAGR
+15.2%/yr
Consistent
Acceleration
+9.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $20.07B | +19.9% |
| 2024 | $16.75B | +17.6% |
| 2023 | $14.24B | +12.3% |
| 2022 | $12.68B | +6.7% |
| 2021 | $11.89B | +19.9% |
| 2020 | $9.91B | -7.7% |
| 2019 | $10.73B | +9.3% |
| 2018 | $9.82B | +8.6% |
| 2017 | $9.05B | +7.9% |
| 2016 | $8.39B | - |